HOME › DRUGS › COSIBELIMAB-IPDL
ACTIVE SUBSTANCE / INN

COSIBELIMAB-IPDL

Brand name(s): UNLOXCYT
FDA LISTED
PRESCRIPTION
BLA761297
ACTIVE SUBSTANCE
Cosibelimab-Ipdl
REGULATORS
FDA
SPONSORS / MAH
CHECKPOINT THERAPEUTICS INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
UNLOXCYTBLA761297CHECKPOINT THERAPEUTICS INCPrescription

FULL INTELLIGENCE ON COSIBELIMAB-IPDL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →